Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARCTURUS: I-01/23 for Fluoropyrimidine Toxicity
NCT07032142Phase 2Not yet recruiting
- Sponsor
- Instituto D’Or de Pesquisa e Ensino
- Start
- Jul 2025
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
A Phase 2 trial of I-01/23 in Fluoropyrimidine Toxicity, sponsored by Instituto D’Or de Pesquisa e Ensino. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
I-01/23
03
Conditions
Fluoropyrimidine Toxicity
Beyond the preview
Go deeper on NCT07032142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07032142.